|
"pan mei ren"的相關文件
顯示項目 1-13 / 13 (共1頁)
1
每頁顯示[10|25|50]項目
| 嘉南藥理大學 |
2023 |
Chromatin Remodeling Enzyme Cluster Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Breast Cancer
|
Kuo, Chia-Yu; Moi, Sin-Hua; Hou, Ming-Feng; Luo, Chi-Wen; Pan, Mei-Ren |
| 嘉南藥理大學 |
2023 |
Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer
|
Wu, Cheng-Che; Pan, Mei-Ren; Shih, Shen-Liang; Shiau, Jun -Ping; Wu, Chun-Chieh; Chang, Shu-Jyuan; Kao, Chieh-Ni; Chen, Fang -Ming; Hou, Ming-Feng; Luo, Chi-Wen |
| 嘉南藥理大學 |
2022 |
Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway
|
Wang, Hui-Ching; Luo, Chi-Wen; Chen, Tzu-Yi; Chen, Yi-Zi; Fang, Shao-Yu; Lai, Chiao-Ying; Hung, Wen-Chun; Wu, Chun-Chieh; Chen, Li-Tzong; Liu, Yi-Chang; Pan, Mei-Ren |
| 嘉南藥理大學 |
2019 |
Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy
|
Wang, Hui-Ching; Chou, Chia-Lin; Yang, Ching-Chieh; Huang, Wei-Lun; Hsu, Yin-Chou; Luo, Chi-Wen; Chen, Tzu-Ju; Li, Chien-Feng; Pan, Mei-Ren |
| 嘉南藥理大學 |
2018 |
Preprogramming therapeutic response of PI3K/mTOR dual inhibitor via the regulation of EHMT2 and p27 in pancreatic cancer
|
Tian, Yu-Feng; Wang, Hui-Ching; Luo, Chi-Wen; Hung, Wen-Chun; Lin, Yu-Han; Chen, Tzu-Yi; Li, Chien-Feng; Lin, Chen-Yi; Pan, Mei-Ren |
| 國立成功大學 |
2016-11 |
Role of epigenetic regulator EHMT2 in the regulation of gemcitabine resistance in pancreatic cancer
|
Hung, Wen-Chun; Pan, Mei-Ren; Hsu, Ming-Chuan; Chen, Li-Tzong; Shan, Yan-Shen |
| 國立成功大學 |
2016-09-20 |
The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer
|
Pan, Mei-Ren; Hsu, Ming-Chuan; Luo, Chi-Wen; Chen, Li-Tzong; Shan, Yan-Shen; Hung, Wen-Chun |
| 國立成功大學 |
2015-12-21 |
G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation
|
Pan, Mei-Ren; Hsu, Ming-Chuan; Chen, Li-Tzong; Hung, Wen-Chun |
| 國立成功大學 |
2009-09-15 |
Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells
|
Pan, Mei-Ren; Chang, Tsung-Ming; Chang, Hui-Chiu; Su, Jen-Liang; Wang, Hsei-Wei; Hung, Wen-Chun |
| 國立成功大學 |
2009-01-30 |
Tubocapsanolide A Inhibits Transforming Growth Factor-beta-activating Kinase 1 to Suppress NF-kappa B-induced CCR7
|
Pan, Mei-Ren; Chang, Hui-Chiu; Wu, Yang-Chang; Huang, Chao-Cheng; Hung, Wen-Chun |
| 國立成功大學 |
2008-06 |
Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases
|
Pan, Mei-Ren; Chang, Hui-Chiu; Hung, Wen-Chun |
| 國立成功大學 |
2008-04-25 |
Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells
|
Pan, Mei-Ren; Hou, Ming-Feng; Chang, Hui-Chiu; Hung, Wen-Chun |
| 高雄醫學大學 |
2008 |
探討抗癌藥物抑制環氧化酶-2對CCR7的表現及調控癌細胞轉移相關基因的分子機制
|
潘美仁; Pan, Mei-Ren |
顯示項目 1-13 / 13 (共1頁)
1
每頁顯示[10|25|50]項目
|
